IP has been the unsung hero, enabling dozens of investigate collaborations and manufacturing partnerships all around the world, often concerning competition. Rivals have shared proprietary compounds, platforms and technologies to build new vaccines in record times. Vaccine developers have joined forces with suppliers all around the world – many of them business competition – to strengthen manufacturing potential.
These partnerships would not materialize without the authorized certainties presented by IP rights. Rip up the rules and the partnerships may crumble. The previous thing the world requirements at this delicate stage is a reshuffling of the deck.
Even extra doubtful is the idea implicit in the WTO proposal that there is spare manufacturing potential that could be harnessed if only IP didn’t stand in the way. In truth, only a handful of nations around the world have this advanced manufacturing potential, and making an attempt to make them in developing nations